Juluca

Active Ingredient(s): Dolutegravir + Rilpivirine
FDA Approved: * November 21, 2017
Pharm Company: * VIIV HLTHCARE
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Juluca Overview

Dolutegravir (DTG), sold under the brand name Tivicay, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.[4] It may also be used, as part of post exposure prophylaxis, to prevent HIV infection following potential exposure.[5] It is taken by mouth.[4] Common side effects include trouble sleeping, feeling tired, diarrhea, high blood sugar, and headache.[5] Severe side effects may include allerg...

Read more Juluca Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dolutegravir

Recent Juluca Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dolutegravir + Rilpivirine
  • Tablet: 50mg + 25mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Juluca: (1 result)

Sorted by National Drug Code
  • 49702-242 Juluca Oral Tablet, Film Coated by Viiv Healthcare Company

Drugs with one or more similar ingredients: (14 results)